《大行报告》大摩上调信义玻璃(00868.HK)目标价至27元 评级「增持」
摩根士丹利发表研究报告指,玻璃行业需求健康,供应有限度增加,令价格保持健康增长势头,预期将继续支持信义玻璃(00868.HK)利润增长。
报告指,浮法玻璃的供应仍受控,只有通过产能置换才能推出新产能,产能增加及健康的需求下,浮法玻璃价格得到良好支持,预期今年新产能受限,净增加量下降至2,050t/d,按年仅增长1.3%。与此同时,今年内地住宅新落成量预期按年增长5%,带动玻璃需求上升。
该行预期,售价及销量提升将支持信义玻璃近期的利润增长,现价相当於未来一年预测市盈率10.2倍,维持「增持」评级,目标价由21.3元上调至27元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.